Nicholas Cross, Thomas Ernst, Jenny Rinke, Hana Žižková, Alfred Cross, Katerina Machova Polakova, Birgit Spiess, William Tapper, Helen White, Andreas Hochhaus. "BCR::ABL1/GUSB halving times predict molecular response to asciminib at 18 months." Blood, 2025. doi:10.1182/blood-2025-5553